HEART FAILURE PRESERVED EJECTION FRACTION
Clinical trials for HEART FAILURE PRESERVED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE PRESERVED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE PRESERVED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can common diabetes drugs help protect hearts and kidneys?
Disease control Recruiting nowThis study aims to understand how a class of drugs called SGLT2 inhibitors affects the long-term health of people who have both chronic kidney disease and a specific type of heart failure (HFpEF). Researchers will observe 200 patients, some taking the drug and some not, to see if…
Matched conditions: HEART FAILURE PRESERVED EJECTION FRACTION
Sponsor: Grigore T. Popa University of Medicine and Pharmacy • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Could a common gout pill help black Veterans' hearts?
Disease control Recruiting nowThis study is testing if Allopurinol, a medication usually used for gout, can improve heart function, exercise ability, and quality of life in African American Veterans with resistant high blood pressure. Researchers will give the drug for 8 weeks to 50 participants to see if it …
Matched conditions: HEART FAILURE PRESERVED EJECTION FRACTION
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC